Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | ZTS | TAK | UTHR | STVN |
| Company | Neurocrine Bioscienc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Stevanato Group S.P.A. |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NYSE |
| Open | 121.30 | 198.23 | 14.82 | 345.46 | 19.87 |
| High | 122.81 | 200.33 | 14.94 | 353.04 | 20.18 |
| Low | 119.66 | 191.31 | 14.82 | 344.47 | 19.81 |
| Last | 120.46 | 193.24 | 14.93 | 351.33 | 19.86 |
| Change | +0.61 | -3.24 | +0.11 | +8.74 | +0.12 |
| % Change | +0.51% | -1.65% | +0.74% | +2.55% | +0.61% |
| Volume | 788,100 | 2,463,000 | 1,119,000 | 454,400 | 285,300 |
| 20-Day Average Volume | 1,169,125 | 1,745,470 | 1,599,820 | 386,115 | 484,415 |
| Previous Close | 119.85 | 196.48 | 14.82 | 342.59 | 19.74 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 128.40 | 187.87 | 14.88 | 348.87 | 20.24 |
| 20-Day Raw Stochastic | 6.57% | 64.81% | 64.29% | 48.35% | 30.99% |
| 20-Day Relative Strength | 34.84% | 61.30% | 61.34% | 57.16% | 48.32% |
| Weighted Alpha | -3.56 | +12.87 | +0.43 | +66.28 | -31.45 |
| Today's Opinion | 40% Sell | 88% Buy | 88% Buy | 100% Buy | 96% Sell |
| Previous Opinion | 40% Sell | 88% Buy | 72% Buy | 88% Buy | 96% Sell |
| Last Month's Opinion | 100% Buy | 72% Buy | 56% Buy | 100% Buy | 80% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.68% since 09/12/24 | +1.33% since 09/12/24 | +0.74% since 09/12/24 | +3.00% since 09/12/24 | +2.90% since 09/12/24 |
| Low | 119.37 on 09/18/24 | 190.13 on 09/13/24 | 14.66 on 09/13/24 | 337.52 on 09/13/24 | 18.87 on 09/17/24 |
| High | 123.57 on 09/16/24 | 200.33 on 09/19/24 | 14.94 on 09/17/24 | 353.63 on 09/17/24 | 20.44 on 09/18/24 |
| 1-Month | |||||
| %Chg | -18.74% since 08/19/24 | +4.75% since 08/19/24 | +1.43% since 08/19/24 | +0.79% since 08/19/24 | -0.70% since 08/19/24 |
| Low | 118.04 on 09/10/24 | 180.18 on 08/23/24 | 14.66 on 09/13/24 | 337.52 on 09/13/24 | 18.36 on 08/26/24 |
| High | 154.87 on 08/23/24 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 366.08 on 09/03/24 | 23.20 on 08/29/24 |
| 3-Month | |||||
| %Chg | -7.95% since 06/18/24 | +13.90% since 06/18/24 | +17.84% since 06/18/24 | +14.80% since 06/18/24 | +13.23% since 06/18/24 |
| Low | 118.04 on 09/10/24 | 166.45 on 06/26/24 | 12.57 on 06/20/24 | 302.71 on 06/20/24 | 16.56 on 06/25/24 |
| High | 157.98 on 08/01/24 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 366.08 on 09/03/24 | 23.20 on 08/29/24 |
| 6-Month | |||||
| %Chg | -14.49% since 03/19/24 | +11.73% since 03/19/24 | +3.61% since 03/19/24 | +46.75% since 03/19/24 | -31.92% since 03/19/24 |
| Low | 118.04 on 09/10/24 | 144.80 on 04/22/24 | 12.57 on 06/20/24 | 221.53 on 04/01/24 | 16.56 on 06/25/24 |
| High | 157.98 on 08/01/24 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 366.08 on 09/03/24 | 33.49 on 03/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,122,732 | 88,174,448 | 47,251,016 | 15,583,590 | 5,869,425 |
| Shares Outstanding, K | 100,637 | 456,295 | 3,164,837 | 44,356 | 295,540 |
| Annual Sales | 1,887,100,000 | 8,544,000,000 | 29,419,960,000 | 2,327,500,000 | 1,174,680,000 |
| Annual Net Income | 249,700,000 | 2,344,000,000 | 994,060,000 | 984,800,000 | 157,620,000 |
| Last Quarter Sales | 590,200,000 | 2,361,000,000 | 7,731,140,000 | 714,900,000 | 279,540,000 |
| Last Quarter Net Income | 65,000,000 | 624,000,000 | 609,590,000 | 278,100,000 | 22,210,000 |
| 60-Month Beta | 0.37 | 0.88 | 0.54 | 0.57 | 0.59 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.63 on 08/01/24 | 1.56 on 08/06/24 | 0.56 on 07/31/24 | 5.85 on 07/31/24 | 0.10 on 08/06/24 |
| Latest Earnings Date | 10/29/24 | 11/07/24 | 10/24/24 | 11/06/24 | 10/29/24 |
| Most Recent Dividend | N/A | 0.432 on 07/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 07/18/24 | 03/27/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 36.21 | 35.47 | 9.44 | 15.74 | 36.56 |